Literature DB >> 15514971

IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR.

Esther A Suswam1, L Burt Nabors, Yuanyuan Huang, Xiuhua Yang, Peter H King.   

Abstract

IL-8 plays an integral role in promoting the malignant phenotype in breast cancer, and its production is directly influenced by inflammatory cytokines in the tumor microenvironment. Here, we show that activation of IL-1beta receptors on malignant HS578t and MDA-MB-231 breast cancer cells strongly induces IL-8 expression and that RNA stabilization is persistently activated at least 12-24 hr after stimulation. SB 203580 and rapamycin reversed the RNA stabilization effect of IL-1beta in a dose-dependent manner, suggesting involvement of the p38/MAP kinase and mTOR pathways. A luciferase reporter assay indicated that the stabilization effect was dependent on cis elements in the 3'-untranslated region (UTR) of the IL-8 transcript. By UV cross-linking, we identified multiple cellular factors that interact with the IL-8 3'UTR, ranging 34-76 kDa. Immunoprecipitation analysis indicated that HuR, KSRP and TIAR bound to one or more loci in the 3'UTR. While the cross-linking patterns were similar, quantitative immunoprecipitation of native IL-8 RNA from IL-1beta-stimulated cytoplasmic extract revealed a 20-fold greater association of transcript with the stabilizing factor HuR vs. the destabilizing factor KSRP. In conclusion, IL-1beta is a potent cytokine stimulus for IL-8 RNA stabilization in breast cancer cells, possibly by enhanced binding of cytoplasmic HuR to the 3'UTR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15514971     DOI: 10.1002/ijc.20675

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

1.  Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells.

Authors:  Sofia Origanti; Shannon L Nowotarski; Theresa D Carr; Suzanne Sass-Kuhn; Lan Xiao; Jian-Ying Wang; Lisa M Shantz
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

Review 2.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

3.  Early downregulation of acute phase proteins after doxorubicin exposition in patients with breast cancer.

Authors:  Carolina Panis; Luciana Pizzatti; Aedra Carla Bufalo; Ana Cristina Herrera; Vanessa Jacob Victorino; Rubens Cecchini; Eliana Abdelhay
Journal:  Tumour Biol       Date:  2015-10-15

4.  Altered PKR Signalling and C / EBPβ Expression is Associated with HLA-B27 Expression in Monocytic Cells.

Authors:  A S Sahlberg; M Ruuska; R A Colbert; K Granfors; M A Penttinen
Journal:  Scand J Immunol       Date:  2012-02       Impact factor: 3.487

Review 5.  Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.

Authors:  Andrii Vislovukh; Thaiz Rivera Vargas; Anna Polesskaya; Irina Groisman
Journal:  World J Biol Chem       Date:  2014-02-26

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.

Authors:  Rohit Upadhyay; Sandhya Sanduja; Vimala Kaza; Dan A Dixon
Journal:  Int J Cancer       Date:  2012-09-18       Impact factor: 7.396

8.  Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.

Authors:  Esther A Suswam; John J Shacka; Kiera Walker; Liang Lu; Xuelin Li; Ying Si; Xiaowen Zhang; Lei Zheng; L Burt Nabors; Heping Cao; Peter H King
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

9.  The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.

Authors:  Robert Calaluce; Matthew M Gubin; J Wade Davis; Joseph D Magee; Jing Chen; Yuki Kuwano; Myriam Gorospe; Ulus Atasoy
Journal:  BMC Cancer       Date:  2010-04-06       Impact factor: 4.430

10.  Intracellular localization and interaction of mRNA binding proteins as detected by FRET.

Authors:  Pamela S David Gerecht; Molly A Taylor; J David Port
Journal:  BMC Cell Biol       Date:  2010-09-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.